Clinical Trials for Metastatic/Locally Advanced Poorly Differentiated NEC

Find clinical trials for metastatic/locally advanced poorly differentiated nec. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)

NCT ID: NCT07016230

The UNLOCK TARLATAMAB trial is studying a new treatment called tarlatamab for patients with advanced small-cell lung cancer (SCLC) and other types of aggressive neuroendocrine cancers. This trial a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Villejuif, , France

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions